These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 22984527)

  • 1. Anti-Müllerian hormone serum values and ovarian reserve: can it predict a decrease in fertility after ovarian stimulation by ART cycles?
    Patrelli TS; Gizzo S; Sianesi N; Levati L; Pezzuto A; Ferrari B; Bacchi Modena A
    PLoS One; 2012; 7(9):e44571. PubMed ID: 22984527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
    Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
    Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment.
    Sadruddin S; Barnett B; Ku L; Havemann D; Mucowski S; Herrington R; Burggren W
    PLoS One; 2020; 15(10):e0239779. PubMed ID: 33044971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
    Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of serum Anti-Müllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients.
    Xi W; Gong F; Lu G
    J Assist Reprod Genet; 2012 May; 29(5):397-402. PubMed ID: 22382641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian response to controlled ovarian hyperstimulation: what does serum FSH say?
    Oudshoorn SC; van Tilborg TC; Hamdine O; Torrance HL; Eijkemans MJC; Lentjes EGWM; Lambalk CB; Broekmans FJM
    Hum Reprod; 2017 Aug; 32(8):1701-1709. PubMed ID: 28854580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship Between Anti-Müllerian Hormone and
    Sun XY; Lan YZ; Liu S; Long XP; Mao XG; Liu L
    Front Endocrinol (Lausanne); 2020; 11():595448. PubMed ID: 33343511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation.
    Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
    Minerva Ginecol; 2017 Jun; 69(3):225-232. PubMed ID: 27352270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of anti-Mullerian hormone for pregnancy outcomes following assisted reproductive techniques (ART) in Southwest China.
    Liu L; Sun XY; Yang H; Feng XJ; Lan YZ
    Reprod Health; 2022 Dec; 19(1):224. PubMed ID: 36514055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity.
    Magri F; Schena L; Capelli V; Gaiti M; Zerbini F; Brambilla E; Rotondi M; De Amici M; Spinillo A; Nappi RE; Chiovato L
    Reprod Biol Endocrinol; 2015 Sep; 13(1):106. PubMed ID: 26391773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles.
    Dai X; Wang Y; Yang H; Gao T; Yu C; Cao F; Xia X; Wu J; Zhou X; Chen L
    Sci Rep; 2020 Nov; 10(1):19750. PubMed ID: 33184364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordance between day-3 follicle stimulating hormone & anti-Müllerian hormone is predictive of clinical pregnancy during fertility treatment.
    Butler WJ; Pico A; Hawkins KC; Younis AI
    Gynecol Endocrinol; 2021 Sep; 37(9):798-801. PubMed ID: 33355011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
    von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
    Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementation with human menopausal gonadotropin in the gonadotropin-releasing hormone antagonist cycles of women with high AMH: Pregnancy outcomes and serial hormone levels.
    Chen LH; Chin TH; Huang SY; Yu HT; Chang CL; Huang HY; Wang HS; Soong YK; Wu HM
    Taiwan J Obstet Gynecol; 2021 Jul; 60(4):739-744. PubMed ID: 34247817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which cut-off value of serum anti-Müllerian hormone level can predict poor ovarian reserve, poor ovarian response to stimulation and in vitro fertilization success? A prospective data analysis.
    Ficicioglu C; Cenksoy PO; Yildirim G; Kaspar C
    Gynecol Endocrinol; 2014 May; 30(5):372-6. PubMed ID: 24576292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.